TRT on TikTok: separating real benefits from bro-science

What did @bull52772 actually say?

The creator made two main technical claims: first, that subcutaneous injection is preferable because it uses a smaller needle and hurts less, and second, that anyone doing intramuscular injection should use the glutes. He also told viewers to "pull the syringe back a little bit" before injecting, which he called aspiration, and warned that hitting a vein causes coughing and feeling unwell. Mixed in with the clinical tips was a pitch to sign up for an online TRT clinic through his referral link.

That last part matters. This is not a neutral educational video. It is a lead-generation post with injection technique as the hook. Viewers should factor that into how they receive the advice.

Does the science back this up?

Partially, but with meaningful caveats. The claim that subcutaneous testosterone injection is viable and less painful than intramuscular is supported by evidence. The aspiration recommendation, however, is more complicated than he made it sound.

A 2017 randomized controlled trial by Spratt et al. published in the Journal of the Endocrine Society found that subcutaneous testosterone cypionate achieved stable serum levels comparable to intramuscular delivery, validating its clinical use. The smaller needle, lower injection volume, and reduced pain are genuine advantages for many patients. The American Urological Association acknowledges subcutaneous as an acceptable route for self-administration.

On aspiration: major nursing and pharmacy bodies, including the CDC and WHO immunization guidelines, stopped recommending aspiration for most injections years ago. The evidence that aspiration prevents intravascular injection is weak, and the major blood vessels at common injection sites run too deep to be easily hit. His framing that aspiration reliably catches vein hits is not well supported by current clinical guidance.

What did they get wrong (or right)?

He got the subcutaneous option right. Recommending it as lower-pain and using a diabetic-style needle is accurate and consistent with how many legitimate TRT clinics now guide patients. Credit where it is due.

The aspiration advice is where things go sideways. His description of what happens if you "hit a vein" is essentially describing an oil embolism, which is a real but rare complication associated with intravascular injection of oil-based testosterone. However, the aspiration technique he describes does not reliably prevent this. A 2020 review by Nicoll and Hesby in the American Journal of Nursing confirmed that aspiration has been removed from standard injection guidance for most sites because there is no strong evidence it reduces complications.

He also says "pull the needle out, switch the locations" if you see blood. This is a reasonable precautionary step even if the underlying rationale is imprecise. So the action is defensible even if the explanation oversimplifies the physiology.

The referral link element deserves separate scrutiny. Recommending people start testosterone therapy based on a TikTok video, without mentioning the need for lab work, physician evaluation, or a diagnosis of hypogonadism, is a real gap. Low testosterone symptoms overlap with thyroid dysfunction, sleep apnea, depression, and other treatable conditions. Skipping proper diagnosis is not a small issue.

What should you actually know?

Testosterone is a controlled substance for a reason. Before anyone starts TRT, they need two morning serum testosterone measurements, a full hormonal workup, and a clinician who has actually reviewed their case. The Endocrine Society's 2018 clinical practice guidelines (Bhasin et al., Journal of Clinical Endocrinology and Metabolism) are explicit that treatment should be reserved for men with confirmed hypogonadism, not just low-normal levels or lifestyle fatigue.

On injection technique specifically:

• Subcutaneous injection of testosterone cypionate or enanthate is clinically accepted and generally well tolerated.
• Ventrogluteal and vastus lateralis sites are often preferred over dorsogluteal in clinical settings because they have fewer nearby nerves and vessels.
• Aspiration is no longer a standard recommendation in most injection protocols according to CDC and WHO guidance, though some providers still advise it.
• Oil embolism from intramuscular testosterone is documented but rare. Slow, careful injection technique and correct site selection reduce risk more reliably than aspiration alone.
• Any online TRT clinic should be ordering labs before prescribing, not just shipping testosterone to your door after a quick form fill.

If you are considering TRT, a legitimate telehealth provider will require blood work first. That is not a bureaucratic hurdle, it is how clinicians confirm you actually need treatment and establish a safe baseline.